Arginase Inhibitor in the Pharmacological Correction of Endothelial Dysfunction

This paper is about a way of correction of endothelial dysfunction with the inhibitor of arginase: L-norvaline. There is an imbalance between vasoconstriction and vasodilatation factors of endothelium on the basis of endothelial dysfunction. Among vasodilatation agents, nitrogen oxide plays the basi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pokrovskiy, Mihail V., Korokin, Mihail V., Tsepeleva, Svetlana A., Pokrovskaya, Tatyana G., Gureev, Vladimir V., Konovalova, Elena A., Gudyrev, Oleg S., Kochkarov, Vladimir I., Korokina, Liliya V., Dudina, Eleonora N., Babko, Anna V., Terehova, Elena G.
Formato: Artigo
Lenguaje:Inglês
Publicado: SAGE-Hindawi Access to Research 2011
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3124670/
https://ncbi.nlm.nih.gov/pubmed/21747978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4061/2011/515047
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares